ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity? Daniele BarbaroFrederik A. VerburgDomenico Rubello Editorial 20 March 2010 Pages: 1251 - 1254
PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications Sandip Basu Editorial 18 March 2010 Pages: 1255 - 1258
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management? Ahmet BiliciBala Basak Oven UstaaliogluMahmut Gumus Original Article 23 March 2010 Pages: 1259 - 1269
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma Amandine PallardyCaroline Bodet-MilinCaroline Rousseau Original Article 20 March 2010 Pages: 1270 - 1278
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma Ferdinand SudbrockMatthias SchmidtHarald Schicha Original Article 24 February 2010 Pages: 1279 - 1290
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer Wenfeng YangYongming ZhangAnqin Han Original Article 23 March 2010 Pages: 1291 - 1299
FDG positron emission tomography/computed tomography studies of Wilms’ tumor A. K. M. Moinul HossainBarry L. ShulkinJeffrey S. Dome Original Article 04 March 2010 Pages: 1300 - 1308
Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1 Mahendranath MoharirKevin LondonKathryn North Original Article 24 February 2010 Pages: 1309 - 1317
18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence Kimiteru ItoJyunkichi YokoyamaHiroshi Matsuda Original Article 20 March 2010 Pages: 1318 - 1327
Optimizing the colloid particle concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer Lenka VermeerenSara H. MullerRenato A. Valdés Olmos Original Article 20 March 2010 Pages: 1328 - 1334
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial D. CordierF. ForrerA. Merlo Original Article 16 February 2010 Pages: 1335 - 1344
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET Maarten BromWim J. G. OyenOtto C. Boerman Original Article Open access 29 January 2010 Pages: 1345 - 1355
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue Vladimir TolmachevIrina VelikyanAnna Orlova Original Article 04 February 2010 Pages: 1356 - 1367
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A″-DTPA-cetuximab Tapan K. NayakCeleste A. S. ReginoMartin W. Brechbiel Original Article 13 February 2010 Pages: 1368 - 1376
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours Andrew MerronPatrick BarilGeorges Vassaux Original Article 06 February 2010 Pages: 1377 - 1385
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues Rogier P. J. SchroederCristina MüllerMarion de Jong Original Article Open access 25 February 2010 Pages: 1386 - 1396
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours Matthias EderStefan KnackmussMichael Eisenhut Original Article 16 February 2010 Pages: 1397 - 1407
Methodological considerations in quantification of oncological FDG PET studies Dennis VriensEric P. VisserWim J. G. Oyen Review Article Open access 20 November 2009 Pages: 1408 - 1425
PET-guided prostate cancer radiotherapy: technological innovations for dose delivery optimisation Giovanni LucignaniHabib Zaidi Focus on 23 April 2010 Pages: 1426 - 1429
Comment on: “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0” Babak SabouryDrew A. TorigianAbass Alavi Letter to the Editor 26 May 2010 Pages: 1430 - 1431
Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging Ronald BoellaardMike J O’Dohertyon behalf of the authors of the guideline “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging” Letter to the Editor Open access 26 May 2010 Pages: 1432 - 1433
The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma Bruno KrugAnne-Sophie PirsonThierry Vander Borght Letter to the Editor 26 May 2010 Pages: 1434 - 1435
Reply to: The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma Roberto C. Delgado-BoltonFelisa Jiménez-RequenaJosé L. Carreras-Delgado Letter to the Editor Open access 26 May 2010 Pages: 1436 - 1437
An unusual looking pacemaker infection imaged with 18F-FDG PET/CT Sophie TurpinRaymond LambertNancy Poirier Image of the Month 07 April 2010 Pages: 1438 - 1438
‘Running on empty’ Damian WildAikaterini TheodorakiBernard Khoo Image of the Month 24 April 2010 Pages: 1439 - 1440
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging Emilio BombardieriValentina AmbrosiniArturo Chiti Guidelines 12 May 2010 Pages: 1441 - 1448